Cited by 57Cutaneous Melanoma Detection and Managementmelanin and skin pigmentationGlobal Cancer Incidence and Screening

Evaluation of the efficacy of 3D total-body photography with sequential digital dermoscopy in a high-risk melanoma cohort: protocol for a randomised controlled trial

Open access
Primiero, Clare Amy, McInerney-Leo, Aideen M, Betz-Stablein, Brigid, Whiteman, David C, Gordon, Louisa, Caffery, Liam, Aitken, Joanne F, Eakin, Elizabeth +6 more·2019·BMJ Open

Abstract

Introduction: Melanoma is Australia’s fourth most common cancer. Early detection is fundamental in maximising health outcomes and minimising treatment costs. To date, population-based screening programmes have not been justified in health economic studies. However, a skin surveillance approach targeting high-risk individuals could improve the cost-benefit ratio. Methods and analysis: This paper describes a 2-year longitudinal randomised controlled trial (RCT) to compare routine clinical care (control) with an intensive skin surveillance programme (intervention) consisting of novel three-dimensional (3D) total-body photography (TBP), sequential digital dermoscopy and melanoma-risk stratification, in a high-risk melanoma cohort. Primary outcomes will evaluate clinical, economic and consumer impact of the intervention. Clinical outcomes will evaluate differences in the rate of lesion excisions/biopsies per person, benign to malignant ratio for excisions and thickness of melanomas diagnosed. A health economic analysis using government data repositories will capture healthcare utilisation and costs relating to skin surveillance. Consumer questionnaires will examine intervention acceptability, the psychological impact, and attitudes towards melanoma risk and sun protective behaviour. Secondary outcomes include the development of a holistic risk algorithm incorporating clinical, phenotypic and genetic factors to facilitate the identification of those most likely to benefit from this surveillance approach. Furthermore, the feasibility of integrating the intervention with teledermatology to enhance specialist care in remote locations will be evaluated. This will be the first RCT to compare a targeted surveillance programme utilising new 3D TBP technology against current routine clinical care for individuals at high risk of melanoma. Ethics and dissemination: This study has received Human Research Ethics Committee (HREC) approval from both Metro South Health HREC (HREC/17/QPAH/816) and The University of Queensland HREC (2018000074). Trial registration number: ANZCTR12618000267257; Pre-results.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/bmjopen-2019-032969

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In clinical validation study, PanDerm effectively identified malignant lesions among large number of benign ones (216 malignant vs 197,716 benign) from HOP and MYM cohorts.

    “In a clinical validation study, PanDerm effectively identified malignant lesions among a large number of benign ones (216 malignant versus 197,716 benign lesions) from the high-risk melanoma of patients (HOP) study49 and mind your model (MYM) study50 cohort (Fig. 4e).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

3 of the 33 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Primiero, C. A., McInerney-Leo, A. M., Betz-Stablein, B., Whiteman, D. C., Gordon, L., Caffery, L., Aitken, J. F., Eakin, E., Osborne, S., Gray, L., Smithers, B. M., Janda, M., Soyer, H. P., & Finnane, A.
Affiliations
  • The University of Queensland (AU)
  • QIMR Berghofer Medical Research Institute (AU)
  • Queensland University of Technology (AU)
  • University of Southern Queensland (AU)
Corresponding author
Soyer, H Peter
Venue
BMJ Open
Publisher
BMJ
Published
2019-11
Volume
9
Issue
11
Pages
e032969
ISSN
2044-6055 (ISSN-L)
OpenAlex
W2983291152
Cited by
57
References
33
Citations by year
2026: 3 · 2025: 15 · 2024: 8 · 2023: 8 · 2022: 8 · 2021: 6 · 2020: 7 · 2019: 1
FWCI
2.30
Type
journal article
Language
en
Open access
Licence
cc-by-nc
Locations
  • BMJ Open (publishedVersion, cc-by-nc)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • QUT ePrints (Queensland University of Technology) (submittedVersion, cc-by-nc)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • HighWire Press Open Archive (submittedVersion)
  • Griffith Research Online (submittedVersion, cc-by-nc)
Funders
  • Princess Alexandra Research Foundation (Translational Research Innovation Award)
  • National Health and Medical Research Council (APP1153046)
  • Queensland Genomics, Queensland Government (M1215057)
  • Brisbane Diamantina Health Partners (Health System Improvement Ideas grant)
Topics
  • Health Sciences › Medicine › Oncology › Cutaneous Melanoma Detection and Management
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › melanin and skin pigmentation
  • Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
Keywords
melanoma, skin surveillance, digital dermoscopy, high-risk melanoma, melanoma risk stratification, melanoma detection, health care costs, teledermatology, sun protection behavior, risk algorithm, early detection
MeSH terms
Australia, Cost-Benefit Analysis, Humans, Melanoma, Photography, Surveys and Questionnaires, Skin Neoplasms, Randomized Controlled Trials as Topic, Imaging, Three-Dimensional, Dermoscopy, Public Health Surveillance

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review